An extra 229,000 deaths: Is that the cost of US-UK drugs deal?

New research warns that a proposed US-UK trade deal could significantly damage the National Health Service. The study finds that requiring Britain to purchase more medicines from the United States would redirect resources away from other critical healthcare services. According to the analysis, this shift could result in an extra two hundred twenty-nine thousand deaths in the UK. The trade agreement would increase American pharmaceutical spending within the NHS, leaving less funding available for other medical needs. According to Al Jazeera, the research raises questions about whether closer trade ties justify the potential health consequences as both countries continue negotiations.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton